ACI
Cleve Tyler took part in a mock trial on "Section 337 Exclusion Orders for New Technology: Examining Public Interest Concerns Potentially Arising from Exclusion Orders." Speakers discussed technologies such as 5G mobile phone technology and biologics products; how the US International Trade Commission has been adapting to new technologies; and whether the same public interest issues that could arise in cases involving biologics could be raised in cases involving biosimilars.
Related Professionals
- 202.480.2727